Pharmacokinetics of FDL169 in Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Cystic Fibrosis

Interventions

DRUG

FDL169

Trial Locations (1)

Simbec Research Ltd, Merthyr Tydfil

All Listed Sponsors

lead

Flatley Discovery Lab LLC

OTHER

NCT02680418 - Pharmacokinetics of FDL169 in Healthy Female Subjects | Biotech Hunter | Biotech Hunter